Abstract
Epigenetic regulation of gene activity is implicated in a number of mental disorders, including developmental disorders of the brain, personality disorders, and deviant behavior. A study of the methylation level of 24 selected CpG sites in the groups of patients with the listed disorders and the control group was carried out. It was shown that CpG sites in the regulatory regions of three genes of human neurotransmitter systems—BDNF, COMT, and CACNA1C—are hypermethylated that may lead to a decrease in the expression of these genes. The results obtained can be used as a basis for the development of diagnostic test systems and the search for pharmacological targets for the detection and correction of such pathologies.




Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.REFERENCES
Sasaki, A., de Vega, W.C., and McGowan, P.O., Biological embedding in mental health: an epigenomic perspective, Biochem. Cell. Biol., 2013, vol. 9, no. 1, pp. 14–21. https://doi.org/10.1139/bcb-2012-0070
Provenkal, N. and Binder, E., The neurobiological effects of stress as contributors to psychiatric disorders: focus on epigenetics, Curr. Opinion Neurobiol., 2015, vol. 30, pp. 31–37. https://doi.org/10.1016/j.conb.2014.08.007
Rozanov, V.A., Epigenetics: stress and behavior, Neurophysiology, 2012, vol. 44, no. 4, pp. 332–350.
McEwen, B., Brain on stress: how the social environment gets under the skin, Proc. Natl. Acad. Sci. U.S.A., 2012, vol. 109, no. 2, pp. 17180–17185.
Campbell, K.A., Colacino, J.A., Park, S.K., and Bakulski, K.M., Cell types in environmental epigenetic studies: biological and epidemiological frameworks, Curr. Environ. Health Rep., 2020, vol. 7, no. 3, pp. 185–197. https://doi.org/10.1007/s40572-020-00287-0
Hing, B., Gardner, C., and Potash, J.B., Effects of negative stressors on DNA methylation in the brain: implications for mood and anxiety disorders, Am. J. Med. Genet. Neuropsychiatr. Genet., 2014, vol. 165B, no. 7, pp. 541–554. https://doi.org/10.1002/ajmg.b.32265
Heller, D., Grodner, D., and Tanenhaus, M.K., The role of perspective in identifying domains of reference, Cognition, 2008, vol. 108, no. 3, pp. 831–836. https://doi.org/10.1016/j.cognition.2008.04.008
Babenko, A.S., Mosse, K.A., Sedlyar, N.G., et al., Development of a panel for analyzing the methylation profile of target epigenetic loci associated with the psychoemotional status of a person, Mol. Prikl. Genet., 2020, vol. 29, pp. 37–48.
Shimizu, E., Hashimoto, K., Okamura, N., et al., Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants, Biol. Psychiatry, 2003, vol. 54, no. 1, pp. 70–75. https://doi.org/10.1016/s0006-3223(03)00181-1
Bocchio-Chiavetto, L., Bagnardi, V., Zanardini, R., et al., Serum and plasma BDNF levels in major depression: a replication study and meta-analyses, World J. Biol. Psychiatry, 2010, vol. 11, no. 6, pp. 763–773. https://doi.org/10.3109/15622971003611319
Terracciano, A., Lobina, M., Grazian Piras, M., et al., Neuroticism, depressive symptoms, and serum BDNF, Psychosom. Med., 2011, vol. 73, no. 8, pp. 638–642. https://doi.org/10.1097/PSY.0b013e3182306a4f
Minelli, A., Zanardini, R., Bonvicini, C., et al., BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects, Eur. Arch. Psychiatry Clin. Neurosci., 2011, vol. 261, no. 5, pp. 323–329. https://doi.org/10.1007/s00406-011-0189-3
Dell’Osso, B., D’Addario, C., Carlotta Palazzo, M., et al., Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients, J. Affect. Disord., 2014, vol. 166, pp. 330–333. https://doi.org/10.1016/j.jad.2014.05.020
Strauss, J.S., Khare, T., and De Luca, V., Quantitative leukocyte BDNF promoter methylation analysis in bipolar disorder, Int. J. Bipolar Disord., 2013, vol. 12, pp. 1–28. https://doi.org/10.1186/2194-7511-1-28
Craddock, N., Owen, M., and O’Donovan, M., The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons, Mol. Psychiatry, 2006, vol. 11, pp. 446–458. https://doi.org/10.1038/sj.mp.4001808
Chen, J., Lipska, B.K., Halim, N., et al., Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain, Am. J. Hum. Genet., 2004, vol. 75, no. 5, pp. 807–821. https://doi.org/10.1086/425589
Hu, X., Oroszi, G., Chun, J., et al., An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk, Alcohol Clin. Exp. Res., 2005, vol. 29, no. 1, pp. 8–16. https://doi.org/10.1097/01.alc.0000150008.68473.62
Zueva, I.B., Ulitina, A.S., Gorab, D.N., et al., The role of allelic variants of the genes of the angiotensin-converting enzyme ACE and serotonin transporter SLC6A4 in the development of cognitive deficit in persons with metabolic syndrome, Arterial. Gipertenz., 2012, vol. 18, no. 6, pp. 531–539.
Norrholm, S.D., Jovanovic, T., Smith, A.K., et al., Differential genetic and epigenetic regulation of catechol-O-methyltransferase is associated with impaired fear inhibition in posttraumatic stress disorder, Front. Behav. Neurosci., 2013, vol. 10, pp. 7–30. https://doi.org/10.3389/fnbeh.2013.00030
Bhat, S., Dao, D.T., Terrillion, C.E., et al., CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease, Prog. Neurobiol., 2012, vol. 99, no. 1, pp. 1–14. https://doi.org/10.1016/j.pneurobio.2012.06.001
Bagot, R.C., Labonte, B., Pena, C.J., and Nestler, E.J., Epigenetic signaling in psychiatric disorders: stress and depression, Dialogues Clin. Neurosci., 2014, vol. 16, no. 3, pp. 281–295. https://doi.org/10.31887/DCNS.2014.16.3/rbagot
Starnawska, A., Demontis, D., Pen, A., et al., CACNA1C hypermethylation is associated with bipolar disorder, Trans. Psychiatry, 2016, vol. 6, no. 6, pp. 1–7. https://doi.org/10.1038/tp.2016.99
Funding
The results obtained in the project “Development of a methodology for determining the status of genetic loci and lifetime modification of DNA sites affecting the psychoemotional status of a person” of the research-and-technological program of the Union State of Russia and Belarus Development of Innovative Genogeographic and Genomic Technologies for Personal Identification and Individual Characteristics of a Person Based on the Study of the Gene Pools of the Regions of the Union State” (“DNA Identification”).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declare that they have no conflicts of interest.
Statement of compliance with standards of research involving humans as subjects. All procedures performed in human research are in accordance with the ethical standards of the institutional and/or national committee on research ethics and the 1964 Declaration of Helsinki and its subsequent amendments or comparable standards of ethics.
Informed voluntary consent was obtained from each of the participants included in the study.
Rights and permissions
About this article
Cite this article
Mosse, I.B., Sedlyar, N.G., Babenko, A.S. et al. Association between Methylation of Neuromediator Brain System Genes and Psychoemotional Human Characteristics. Russ J Genet 57, 1424–1429 (2021). https://doi.org/10.1134/S1022795421120115
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795421120115

